Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmine Carbone

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 2, 2012
A novel design of ventricular assist device: an in vitro feasibility studyAntonio Boccaccio, Carmine Carbone, Umberto Galietti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 28, 2008
Surgical strategy for acute type A aortic dissection in octogenarianAlessio Amico, Luca Caprili, Nasser Asgharnejad Fahim, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 18, 2017
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapyRaffaela Santoro, Carmine Carbone, Geny Piro, et al.
Anticancer Research|March 31, 2018
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional ActivityRaffaela Santoro, Marco Zanotto, Carmine Carbone, et al.
Parasites & Vectors|October 16, 2020
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasisNatalia Tiberti, Dora Buonfrate, Carmine Carbone, et al.
Cells|October 14, 2022
Immunogenic Cell Death: An Emerging Target in Gastrointestinal CancersMarta Chiaravalli, Alexia Spring, Antonio Agostini, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
International Journal of Molecular Sciences|June 10, 2023
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of TherapyEnrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
Nutrients|April 23, 2022
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary ApproachesChiara Cencioni, Ilaria Trestini, Geny Piro, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 2, 2012
A novel design of ventricular assist device: an in vitro feasibility studyAntonio Boccaccio, Carmine Carbone, Umberto Galietti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 28, 2008
Surgical strategy for acute type A aortic dissection in octogenarianAlessio Amico, Luca Caprili, Nasser Asgharnejad Fahim, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 18, 2017
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapyRaffaela Santoro, Carmine Carbone, Geny Piro, et al.
Anticancer Research|March 31, 2018
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional ActivityRaffaela Santoro, Marco Zanotto, Carmine Carbone, et al.
Parasites & Vectors|October 16, 2020
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasisNatalia Tiberti, Dora Buonfrate, Carmine Carbone, et al.
Cells|October 14, 2022
Immunogenic Cell Death: An Emerging Target in Gastrointestinal CancersMarta Chiaravalli, Alexia Spring, Antonio Agostini, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
International Journal of Molecular Sciences|June 10, 2023
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of TherapyEnrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
Nutrients|April 23, 2022
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary ApproachesChiara Cencioni, Ilaria Trestini, Geny Piro, et al.
Pageof 11